Eptinezumab-jjmr (Vyepti, Lundbeck) decreased mean monthly migraine days in adult patients in 2 phase 3 clinical trials.
Headache and Migraine
Eli Lilly’s lasmiditan (Reyvow) C-V 50 mg and 100 mg for the acute treatment of migraine is now available for prescription.
Allergan’s positive phase 3 trial results indicate a potential use for the CGRP receptor agonist.
From medications to novel treatment methods, a guide to helping your migraine patients.
Currently under DEA review.